Quick Answer
Outset Medical, Inc. reported Gross Profit of $46.75 million for the year ending 2025.
- Outset Medical, Inc. showed an increase of +21.2% in Gross Profit from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$5.26 million | Q2 2019: -$4.47 million | Q3 2019: -$5.29 million | Q4 2019: -$2.78 million | Q1 2020: -$3.56 million | Q2 2020: -$4.76 million | Q3 2020: -$5.13 million | Q4 2020: $417.0 thousand | Q1 2021: $289.0 thousand | Q2 2021: $1.05 million | Q3 2021: $2.95 million | Q1 2022: $4.44 million | Q2 2022: $3.78 million | Q3 2022: $4.34 million | Q1 2023: $6.43 million | Q2 2023: $7.70 million | Q3 2023: $7.16 million | Q1 2024: $8.22 million | Q2 2024: $9.78 million | Q3 2024: $9.82 million | Q1 2025: $11.07 million | Q2 2025: $11.87 million | Q3 2025: $11.59 million.
- Over the full 8 years of available data (2018 to 2025), Outset Medical, Inc.'s Gross Profit has grown by 864.6%.
- Historical annual values: Fiscal year 2025: $46.75 million | Fiscal year 2024: $38.56 million | Fiscal year 2023: $29.00 million | Fiscal year 2022: $17.83 million | Fiscal year 2021: $7.61 million | Fiscal year 2020: -$13.04 million | Fiscal year 2019: -$17.80 million | Fiscal year 2018: -$6.12 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: